drugset / Trial / NCT06266000

Comparison of 2 Extracts of Saw Palmetto Versus Placebo on Lower Urinary Tract Symptoms (LUTS) and Urinary Frequency

NCT06266000 ↗

Phase 4 Completed 89 enrolled RDC Clinical Pty Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

A randomized, double-blind, placebo-controlled, parallel group study to compare 2 extracts of saw palmetto versus placebo on lower urinary tract symptoms and urinary frequency in 120 generally healthy participants, 45 - 80 years.

Timeline

Start
2024-06-21
Primary completion
2025-06-04
Completion
2025-06-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Commercial Saw palmetto extract Unknown 320 mg —
Subject Saw Palmetto Unknown 320 mg —

Indications

No indication recorded.